COMPANY

Edwards Lifesciences

FDA-cleared device company Past trials only

420 open jobs · last seen Oct 23, 2026 · 67 sources

Location: Irvine, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Aortic Valve Stenosis Tricuspid Regurgitation Mitral Regurgitation Mitral Valve Insufficiency Heart Valve Diseases Heart Diseases Cardiovascular Diseases Tricuspid Valve Insufficiency Heart Failure Pulmonary Valve Insufficiency Complex Congenital Heart Defect Congenital Heart Disease Tricuspid Valve Disease Tricuspid Valve Regurgitation Mitral Stenosis Aortic Stenosis Aortic Valve Insufficiency Tetralogy of Fallot Pulmonary Regurgitation Aortic Valve Replacement Aortic Valve Disease Severe Aortic Stenosis Mitral Valve Regurgitation (Degenerative or Functional) Mitral Insufficiency Dysfunctional RVOT Conduit Pulmonary Valve Degeneration Mitral Valve Regurgitation Mitral Valve Disease Tricuspid Insufficiency RVOT Anomaly Mitral Disease Atrial Appendage Degenerative Mitral Valve Disease Functional Mitral Regurgitation Cardiopulmonary Bypass Surgery Mitral Valve Replacement Calcific Aortic Stenosis Pulmonary Valve Stenosis Congenital Heart Defects

420+1 patient-care hiddenOpen jobs 128Trials (company is sponsor)17FDA records (2 yrs)

Hiring

Title	Location (from posting)	Employer posted	First seen
Chemist I	Spain - Moncada - Valencia	Oct 23, 2026	Oct 23, 2026
Sales Rep, TMTT, Tokyo	Japan-Tokyo	Oct 23, 2026	Oct 23, 2026
Senior Territory Manager, THV	Australia-Queensland-Remote	Oct 22, 2026	Oct 12, 2026
Director, Regulatory Counsel	6 locations, including California Irvine, USA	Oct 22, 2026	Oct 12, 2026
Patent Prosecutor	USA - California – Irvine	Oct 22, 2026	Oct 12, 2026

See all 420 jobs

Trial and FDA signals

New trial + clinical hiring Started an interventional study with no drug phase (NCT07466745, actual start Jul 27, 2026); 20 clinical-operations roles open. ClinicalTrials.gov NCT07466745 (Jul 27, 2026)
Evidence (1 event)
- Jul 27, 2026 · ClinicalTrials.gov NCT07466745
  leadSponsor.name='Edwards Lifesciences'; phases=['NA']; overallStatus=RECRUITING; startDateStruct={date:2026-07-27,type:ACTUAL}; studyFirstPostDate=2026-03-12; briefTitle='Autus Valve Continued Access Study (CAS)'
Device approval + hiring FDA PMA device approval for Autus Size-Adjustable Valve (P260007, Oct 1, 2026; +1 other approval); 218 manufacturing/quality or commercial roles open. FDA P260007 (Oct 1, 2026)
Evidence (2 events)
- Oct 1, 2026 · FDA P260007
  openFDA device/pma: pma_number=P260007; supplement_number=(none); applicant='Edwards Lifesciences, LLC'; decision_code=APPR; decision_date=2026-10-01; trade_name='Autus Size-Adjustable Valve'
- Dec 22, 2025 · FDA P250019
  openFDA device/pma: pma_number=P250019; supplement_number=(none); applicant='Edwards Lifesciences, LLC'; decision_code=APPR; decision_date=2025-12-22; trade_name='SAPIEN M3 Transcatheter Mitral Valve Replacement System'

Job counts as of Oct 18, 2026. All trial and FDA signals

Timeline

2028-06 Trial start —: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study source ↗
2027-01 Trial start Not phased (device or behavioral study): ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral source ↗
Oct 15, 2026 Trial start —: The CLASP III TR CED Study source ↗
2026-10 Trial start Not phased (device or behavioral study): Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System source ↗
Sep 30, 2026 Trial start —: CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for E source ↗
2026-08 Trial start —: TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study) source ↗
Jul 27, 2026 Trial start Not phased (device or behavioral study): Autus Valve Continued Access Study (CAS) source ↗
Jun 26, 2026 FDA FDA 510(k) clearance: ECLIPTIS Left Atrial Appendage Exclusion System (ECS135); ECLIPTIS Left Atrial Appendage Exclusion System (ECS140); ECLIPTIS Left Atrial Appendage Exclusion System (ECS145); ECLI source ↗
Jun 25, 2026 Trial start —: KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance source ↗
Jun 11, 2026 FDA FDA 510(k) clearance: Respiration Rate algorithm — K251326, Jun 11, 2026. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Jun 5, 2026 FDA FDA 510(k) clearance: Fogarty Spring Clips, Handleless Clamps, and Clamp Inserts — K260105, Jun 5, 2026. Applicant at approval: Edwards Lifesciences. source ↗
Apr 17, 2026 FDA FDA 510(k) clearance: Edwards eSheath+ introducer set — K254279, Apr 17, 2026. Applicant at approval: Edwards Lifesciences. source ↗
Feb 24, 2026 FDA FDA 510(k) clearance: HemoSphere Nano Monitor (HSNANO1) — K253186, Feb 24, 2026. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Dec 22, 2025 FDA FDA PMA approval: SAPIEN M3 Transcatheter Mitral Valve Replacement System — P250019, Dec 22, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Dec 18, 2025 FDA FDA 510(k) clearance: HemoSphere Alta Advanced Monitoring Platform (ALTAALL1; ALTACR1; ALTASR1) — K252533, Dec 18, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Oct 21, 2025 FDA FDA 510(k) clearance: HemoSphere Stream Module — K253034, Oct 21, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Sep 23, 2025 FDA FDA 510(k) clearance: Edwards MC3 Tricuspid annuloplasty ring (4900) — K251982, Sep 23, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Sep 17, 2025 FDA FDA 510(k) clearance: Carpentier-Edwards Physio Annuloplasty Ring (4450) — K251688, Sep 17, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Aug 29, 2025 FDA FDA 510(k) clearance: Edwards eSheath Optima introducer set — K252364, Aug 29, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Jul 30, 2025 Trial start —: Real World Data Collection on the INSPIRIS RESILIA Aortic Valve source ↗
Jul 23, 2025 FDA FDA 510(k) clearance: HemoSphere Advanced Monitor (HEM1); HemoSphere Technology Module (HEMTOM10); HemoSphere ClearSight Module (HEMCSM10); Smart Pressure Controller (PC1Q); Acumen IQ Plus Finger Cuff source ↗
Jul 8, 2025 Trial start —: MITRIS China Post Market Clinical Follow-up (PMCF) Study source ↗
May 15, 2025 FDA FDA 510(k) clearance: Hypertension Prediction Index (HePI) Algorithm — K242518, May 15, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Mar 27, 2025 FDA FDA 510(k) clearance: Edwards eSheath Optima introducer set — K244046, Mar 27, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Mar 21, 2025 FDA FDA 510(k) clearance: FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors — K242909, Mar 21, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗

Showing 25 of 67 dated events.

Upcoming milestones

Nov 1, 2026 (ESTIMATED) · Not phased · ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System · NCT05686317
2026-12 (ESTIMATED) · · Real World Data Collection on the INSPIRIS RESILIA Aortic Valve · NCT07120048
2026-12 (ESTIMATED) · Not phased · COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction · NCT02744677
Dec 31, 2026 (ESTIMATED) · Not phased · Clinical Study of Edwards Cardioband FIT Valve Repair System · NCT03382457
2027-02 (ESTIMATED) · Not phased · Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System · NCT07858799
2027-04 (ESTIMATED) · Not phased · Early Feasibility Study - Edwards APTURE Transcatheter Shunt System · NCT03523416
2027-07 (ESTIMATED) · Not phased · ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve · NCT05172960
Jul 10, 2027 (ESTIMATED) · · CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Excl · NCT07742839

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) Showing 50 of 128

Record	Title	Phase	Status	Start	Primary completion
NCT05172973	ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves	Not phased (device or behavioral study)	Recruiting	Nov 22, 2023	2029-03 (estimated)
NCT03779490	Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)	Not listed	Active, not recruiting	Jul 24, 2019	Sep 30, 2022 (actual)
NCT04153292	The ENCIRCLE Trial	Not phased (device or behavioral study)	Active, not recruiting	Nov 12, 2020	Oct 10, 2027 (estimated)
NCT07859709	The CLASP III TR CED Study	Not listed	Not yet recruiting	Oct 15, 2026	Dec 31, 2030 (estimated)
NCT07858799	Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System	Not phased (device or behavioral study)	Recruiting	2026-10	2027-02 (estimated)
NCT05378386	ALTERRA Post-Approval Study	Not listed	Active, not recruiting	May 12, 2022	Sep 25, 2025 (actual)
NCT03523416	Early Feasibility Study - Edwards APTURE Transcatheter Shunt System	Not phased (device or behavioral study)	Recruiting	Jul 31, 2018	2027-04 (estimated)
NCT05404880	INSPIRIS China PMCF Study	Not listed	Active, not recruiting	Jul 13, 2022	2034-03 (estimated)
NCT07619872	KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance	Not listed	Recruiting	Jun 25, 2026	Dec 31, 2028 (estimated)
NCT07120048	Real World Data Collection on the INSPIRIS RESILIA Aortic Valve	Not listed	Recruiting	Jul 30, 2025	2026-12 (estimated)
NCT06833476	TTVR STRONG Under Coverage With Evidence Development (CED) Study	Not listed	Recruiting	Mar 19, 2025	Dec 30, 2027 (estimated)
NCT05006404	Autus Valve Pivotal Study	Not phased (device or behavioral study)	Active, not recruiting	Feb 5, 2024	Aug 24, 2026 (actual)
NCT03230747	SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation	Not phased (device or behavioral study)	Completed	Sep 14, 2017	Jun 16, 2021 (actual)
NCT05172960	ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve	Not phased (device or behavioral study)	Recruiting	Jun 20, 2022	2027-07 (estimated)
NCT04919980	TVMR With the INNOVALVE System Trial - Early Feasibility Study	Not phased (device or behavioral study)	Recruiting	Sep 1, 2022	Jul 1, 2028 (estimated)
NCT04097145	Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial	Not phased (device or behavioral study)	Recruiting	Dec 11, 2019	Dec 31, 2027 (estimated)
NCT06569602	Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)	Not listed	Recruiting	Oct 1, 2024	Sep 30, 2030 (estimated)
NCT04375332	Beating Heart Mitral Valve Repair With the HARPOON™ System	Not phased (device or behavioral study)	Active, not recruiting	Dec 16, 2020	Dec 20, 2027 (estimated)
NCT04430075	MiCLASP Post Market Clinical Follow-Up (PMCF) Study	Not listed	Active, not recruiting	Aug 23, 2019	Sep 4, 2025 (actual)
NCT05168826	China S3 PMS: SAPIEN 3 China Post Market Registry Study	Not listed	Active, not recruiting	Jan 24, 2022	2035-12 (estimated)
NCT07466745	Autus Valve Continued Access Study (CAS)	Not phased (device or behavioral study)	Recruiting	Jul 27, 2026	Oct 30, 2027 (estimated)
NCT04902053	INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study	Not listed	Suspended	2028-06	2030-12 (estimated)
NCT07742839	CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery.	Not listed	Not yet recruiting	Sep 30, 2026	Jul 10, 2027 (estimated)
NCT02744677	COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction	Not phased (device or behavioral study)	Recruiting	Jul 5, 2016	2026-12 (estimated)
NCT04614402	Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System	Not listed	Active, not recruiting	Jan 15, 2021	Apr 20, 2023 (actual)
NCT03745313	Edwards CLASP TR EFS	Not phased (device or behavioral study)	Completed	Feb 5, 2019	May 11, 2021 (actual)
NCT03706833	Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial	Not phased (device or behavioral study)	Active, not recruiting	Nov 30, 2018	Jun 30, 2026 (estimated)
NCT07684313	TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)	Not listed	Not yet recruiting	2026-08	2030-08 (estimated)
NCT05083403	HPI (Hypotension Prediction Index) Care Trial	Not phased (device or behavioral study)	Terminated	Mar 28, 2022	May 14, 2024 (actual)
NCT05686317	ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System	Not phased (device or behavioral study)	Active, not recruiting	Apr 1, 2023	Nov 1, 2026 (estimated)
NCT05526560	Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve	Not listed	Active, not recruiting	Jan 11, 2023	2028-01 (estimated)
NCT03382457	Clinical Study of Edwards Cardioband FIT Valve Repair System	Not phased (device or behavioral study)	Active, not recruiting	Jul 1, 2018	Dec 31, 2026 (estimated)
NCT04221490	2019-06 TRISCEND Study	Not phased (device or behavioral study)	Active, not recruiting	May 6, 2020	Jan 5, 2024 (actual)
NCT01757665	ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)	Not phased (device or behavioral study)	Completed	Dec 11, 2012	2017-08 (actual)
NCT04555967	SAPIEN 3 Ultra System PMCF	Not listed	Active, not recruiting	Jun 30, 2020	Sep 24, 2021 (actual)
NCT02718001	Edwards EVOQUE Eos MISCEND Study	Not phased (device or behavioral study)	Active, not recruiting	Feb 6, 2015	Apr 30, 2028 (estimated)
NCT04482062	TRISCEND II Pivotal Trial	Not phased (device or behavioral study)	Active, not recruiting	Apr 9, 2021	Dec 5, 2025 (actual)
NCT03170349	The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study	Not phased (device or behavioral study)	Completed	Jun 27, 2017	Jul 30, 2020 (actual)
NCT04860765	COMPASSION S3 Post-Approval Study	Not listed	Active, not recruiting	Apr 13, 2021	2030-08 (estimated)
NCT04000607	Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)	Not phased (device or behavioral study)	Active, not recruiting	Jul 10, 2019	Nov 3, 2023 (actual)
NCT02675114	PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis	Not phased (device or behavioral study)	Active, not recruiting	2016-03	Nov 16, 2020 (actual)
NCT07059793	MITRIS China Post Market Clinical Follow-up (PMCF) Study	Not listed	Recruiting	Jul 8, 2025	2028-12 (estimated)
NCT06167213	ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral	Not phased (device or behavioral study)	Not yet recruiting	2027-01	2029-03 (estimated)
NCT04889872	PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR	Not phased (device or behavioral study)	Recruiting	Oct 12, 2021	2029-06 (estimated)
NCT02987387	COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction	Not listed	Completed	Jul 17, 2017	Aug 9, 2021 (actual)
NCT03517436	ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis	Not phased (device or behavioral study)	Active, not recruiting	Sep 18, 2018	Oct 2, 2020 (actual)
NCT03193801	PARTNER 3 Trial - Mitral Valve in Valve	Not phased (device or behavioral study)	Active, not recruiting	Feb 1, 2018	Aug 16, 2022 (actual)
NCT03130777	ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent	Not phased (device or behavioral study)	Active, not recruiting	Aug 22, 2017	Jul 14, 2022 (actual)
NCT03466918	China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population	Not phased (device or behavioral study)	Completed	May 23, 2018	Jul 3, 2019 (actual)
NCT04860752	SAPIEN 3 Ultra EU PMS	Not listed	Completed	Apr 20, 2021	Jul 22, 2024 (actual)

FDA records (last 2 years)

Jun 26, 2026 FDA 510(k) clearance: ECLIPTIS Left Atrial Appendage Exclusion System (ECS135); ECLIPTIS Left Atrial Appendage Exclusion System (ECS140); ECLIPTIS Left Atrial Appendage Exclusion System (ECS145); ECLIPTIS Left Atrial Appendage Exclusion System (ECS150) — K254232, Jun 26, 2026. Applicant at approval: Edwards Lifesciences. source ↗
Jun 11, 2026 FDA 510(k) clearance: Respiration Rate algorithm — K251326, Jun 11, 2026. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Jun 5, 2026 FDA 510(k) clearance: Fogarty Spring Clips, Handleless Clamps, and Clamp Inserts — K260105, Jun 5, 2026. Applicant at approval: Edwards Lifesciences. source ↗
Apr 17, 2026 FDA 510(k) clearance: Edwards eSheath+ introducer set — K254279, Apr 17, 2026. Applicant at approval: Edwards Lifesciences. source ↗
Feb 24, 2026 FDA 510(k) clearance: HemoSphere Nano Monitor (HSNANO1) — K253186, Feb 24, 2026. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Dec 22, 2025 FDA PMA approval: SAPIEN M3 Transcatheter Mitral Valve Replacement System — P250019, Dec 22, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Dec 18, 2025 FDA 510(k) clearance: HemoSphere Alta Advanced Monitoring Platform (ALTAALL1; ALTACR1; ALTASR1) — K252533, Dec 18, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Oct 21, 2025 FDA 510(k) clearance: HemoSphere Stream Module — K253034, Oct 21, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Sep 23, 2025 FDA 510(k) clearance: Edwards MC3 Tricuspid annuloplasty ring (4900) — K251982, Sep 23, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Sep 17, 2025 FDA 510(k) clearance: Carpentier-Edwards Physio Annuloplasty Ring (4450) — K251688, Sep 17, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Aug 29, 2025 FDA 510(k) clearance: Edwards eSheath Optima introducer set — K252364, Aug 29, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Jul 23, 2025 FDA 510(k) clearance: HemoSphere Advanced Monitor (HEM1); HemoSphere Technology Module (HEMTOM10); HemoSphere ClearSight Module (HEMCSM10); Smart Pressure Controller (PC1Q); Acumen IQ Plus Finger Cuff (AIQCA2); HemoSphere Pressure Cable (HEMPSC100); HemoSphere Vita Monitor (HEMVITA1); HemoSphere Vita Technology Module (H — K243781, Jul 23, 2025. Applicant at approval: Edwards Lifesciences. source ↗
May 15, 2025 FDA 510(k) clearance: Hypertension Prediction Index (HePI) Algorithm — K242518, May 15, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Mar 27, 2025 FDA 510(k) clearance: Edwards eSheath Optima introducer set — K244046, Mar 27, 2025. Applicant at approval: Edwards Lifesciences. source ↗
Mar 21, 2025 FDA 510(k) clearance: FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors — K242909, Mar 21, 2025. Applicant at approval: Edwards Lifesciences, LLC. source ↗
Dec 9, 2024 FDA 510(k) clearance: HemoSphere Alta Advanced Monitoring Platform (ALTAALL1/ALTCR1/ALTASR1); HemoSphere Alta- monitor pressure cable (HEMAPSC200);Acumen AFM cable- HemoSphere Alta monitor (HEMAFM100) — K242451, Dec 9, 2024. Applicant at approval: Edwards Lifesciences. source ↗
Oct 16, 2024 FDA 510(k) clearance: Cerebral Autoregulation Index (CAI) Algorithm — K240596, Oct 16, 2024. Applicant at approval: Edwards Lifesciences. source ↗

Open jobs 420

1 patient-care job hidden (phlebotomy, plasma-center, nursing and similar care roles; 421 open jobs in total).

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Chemist I	Spain - Moncada - Valencia	Oct 23, 2026	Oct 23, 2026	Not stated
Sales Rep, TMTT, Tokyo	Japan-Tokyo	Oct 23, 2026	Oct 23, 2026	Not stated
Senior Territory Manager, THV	Australia-Queensland-Remote	Oct 22, 2026	Oct 12, 2026	Not stated
Director, Regulatory Counsel	6 locations, including California Irvine, USA	Oct 22, 2026	Oct 12, 2026	Senior
Patent Prosecutor	USA - California – Irvine	Oct 22, 2026	Oct 12, 2026	Mid
テリトリーマネージャー, THV, 東京	Japan-Tokyo HQ	Oct 22, 2026	Oct 12, 2026	Mid
Senior Engineer, NPD Manufacturing	USA - California – Irvine	Oct 22, 2026	Oct 17, 2026	Not stated
Associate Contracts Analyst	Irvine, CA	Oct 22, 2026	Oct 23, 2026	Not stated
Inspector	USA - Utah – Salt Lake City	Oct 22, 2026	Oct 23, 2026	Not stated
Senior Packager, Pilot	USA - California – Irvine	Oct 22, 2026	Oct 23, 2026	Not stated
Senior Inspector, Pilot	USA - California – Irvine	Oct 22, 2026	Oct 23, 2026	Not stated
Technician, Pilot Quality	USA - California – Irvine	Oct 22, 2026	Oct 23, 2026	Not stated
Area Sales Manager, Long Island, IHFM	USA - New York – Long Island	Oct 22, 2026	Oct 23, 2026	Not stated
Senior Engineer, Manufacturing	USA - Utah – Salt Lake City	Oct 22, 2026	Oct 23, 2026	Not stated
Director of Engineering, Advanced Catheters PEG	USA - Utah – Salt Lake City	Oct 22, 2026	Oct 23, 2026	Not stated
Senior Supervisor, Manufacturing	Costa Rica-Cartago-Wet Plant	Oct 22, 2026	Oct 23, 2026	Not stated
Senior Biostatistician	USA - California – Irvine	Oct 22, 2026	Oct 23, 2026	Not stated
障碍者採用 Analyst, Sales Strategy and Operations	Japan-Tokyo	Oct 22, 2026	Oct 23, 2026	Not stated
Sr AP Accountant, Accounting	Czech Republic-Prague	Oct 22, 2026	Oct 23, 2026	Not stated
Sales Rep, TMTT, Osaka	Japan-Osaka	Oct 22, 2026	Oct 23, 2026	Not stated
Senior Technician, Maintenance	USA - California – Irvine	Oct 21, 2026	Oct 12, 2026	Senior
Associate Rep, Training Systems	USA - California – Irvine	Oct 21, 2026	Oct 12, 2026	Entry
Sr Developer, ServiceNow HRSD	2 locations (listed on the posting)	Oct 21, 2026	Oct 12, 2026	Senior
Product Marketing Manager, Surgical	India-Mumbai	Oct 21, 2026	Oct 12, 2026	Mid
Manager, Business Continuity	Costa Rica-Cartago-BSC	Oct 21, 2026	Oct 12, 2026	Not stated
Field Clinical Specialist, Memphis, TMTT	USA - Tennessee - Memphis	Oct 21, 2026	Oct 17, 2026	Not stated
Second Shift Associate Inspector (Metals)	USA - Utah – Salt Lake City	Oct 21, 2026	Oct 23, 2026	Not stated
Principal Engineer, R&D	USA - California – Irvine	Oct 21, 2026	Oct 23, 2026	Not stated
Product Specialist	China-Zhengzhou-Field	Oct 21, 2026	Oct 23, 2026	Not stated
Engineer I , Manufacturing	Singapore	Oct 21, 2026	Oct 23, 2026	Not stated
Senior Director of Health Systems Partnerships (National Accounts) - THV	12 locations, including Boston, Mass, USA	Oct 20, 2026	Oct 12, 2026	Senior
Senior Manager, Lifecycle Management	USA - California – Irvine	Oct 20, 2026	Oct 12, 2026	Not stated
テリトリーマネージャー, THV, 大阪	Japan-Osaka	Oct 20, 2026	Oct 12, 2026	Mid
Senior Manufacturing Engineer, Pilot	USA - California – Irvine	Oct 20, 2026	Oct 14, 2026	Not stated
Production Supply Clerk	USA - Utah – Salt Lake City	Oct 20, 2026	Oct 14, 2026	Not stated
Territory Manager TMTT - East Canada	Canada-Montreal-Field	Oct 20, 2026	Oct 17, 2026	Not stated
Senior Manager, Project Management	USA - California – Irvine	Oct 20, 2026	Oct 20, 2026	Not stated
Associate Heart Valve Specialist	Singapore	Oct 20, 2026	Oct 20, 2026	Not stated
Principal Biostatistician	USA - California – Irvine	Oct 20, 2026	Oct 23, 2026	Not stated
Senior Microbiologist	Irvine, CA	Oct 20, 2026	Oct 23, 2026	Not stated
THV Field Clinical Specialist(m/f/d) - Paris & Ile-de-France	2 locations (listed on the posting)	Oct 20, 2026	Oct 23, 2026	Not stated
Regional Director, Southern CA – Transcatheter Heart Valve	2 locations, including California Irvine, USA	Oct 20, 2026	Oct 23, 2026	Not stated
Commercial Inventory Analyst	USA - California – Irvine	Oct 19, 2026	Oct 12, 2026	Not stated
Senior Manager, Program Management, Software	USA - California – Irvine	Oct 19, 2026	Oct 12, 2026	Senior
Director, AI Clinical Operations & Regulatory	USA - California – Irvine	Oct 19, 2026	Oct 12, 2026	Senior
Senior Biostatistician	Irvine, CA	Oct 19, 2026	Oct 20, 2026	Not stated
Principal Engineer, NPD-Quality	USA - California – Irvine	Oct 19, 2026	Oct 20, 2026	Not stated
Senior Analyst, Project Management	USA - Utah – Salt Lake City	Oct 19, 2026	Oct 20, 2026	Not stated
Senior Engineer, Packaging	USA - California – Irvine	Oct 19, 2026	Oct 20, 2026	Not stated
Territory Manager, South Jersey- Transcatheter Heart Valve	USA - New Jersey – Cherry Hill	Oct 19, 2026	Oct 20, 2026	Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

All 420 jobs →

Connect

See your connections at Edwards Lifesciences on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12